No cART initiation | Time since cART initiation, <3 months |
Time since cART initiation, ≥3 months | ||||
---|---|---|---|---|---|---|
Baseline characteristics | Cases, N |
HR | Cases, N | HR | Cases, N | HR |
CD4 count, cells/mm3 | ||||||
<50 | 20 | 1 | 11 | 0.59 (0.25–1.40) | 29 | 0.18 (0.09–0.35) |
50 – 100 | 20 | 1 | 3 | 0.33 (0.06–1.71) | 20 | 0.08 (0.02–0.29) |
100 – 200 | 26 | 1 | 3 | 0.16 (0.05–0.55) | 41 | 0.15 (0.05–0.04) |
200 – 350 | 53 | 1 | 9 | 1.33 (0.34–5.13) | 47 | 0.11 (0.05–0.25) |
≥350 | 156 | 1 | 10 | 0.62 (0.22–1.73) | 87 | 0.17 (0.11–0.29) |
HIV-RNA, log10 copies/mL | ||||||
<4 | 47 | 1 | 3 | 0.63 (0.16–2.43) | 32 | 0.49 (0.24–0.99) |
4–5 | 129 | 1 | 12 | 1.20 (0.41–3.52) | 93 | 0.11 (0.06–0.19) |
>5 | 99 | 1 | 21 | 0.44 (0.26–0.74) | 99 | 0.14 (0.09–0.22) |
Age, years | ||||||
< 35 | 111 | 1 | 8 | 0.26 (0.12–0.58) | 101 | 0.12 (0.06–0.23) |
35 – 50 | 137 | 1 | 24 | 1.24 (0.52–2.95) | 80 | 0.12 (0.07–0.20) |
≥50 | 27 | 1 | 4 | 0.44 (0.15–1.32) | 43 | 0.22 (0.09–0.56) |
Sex | ||||||
Male | 205 | 1 | 27 | 0.89 (0.40–1.98) | 162 | 0.13 (0.08–0.21) |
Female | 70 | 1 | 9 | 0.46 (0.18–1.17) | 62 | 0.13 (0.06–0.26) |